Connect with us

Health

Neutralizing Antibodies Making Their Mark in Next Wave of Biologics – Genetic Engineering & Biotechnology News

In this eBook we highlight the research efforts and related applications utilized to study binding affinity, potency and target specificities of neutralizing antibodies…

Published

on

Article feature image

View eBook
 
In the last couple of years, there has been heightened interest in the development of Monoclonal antibodies (mAbs) as therapeutics as they have shown great promise in the treatment of serious or untreatable conditions such as cancer. This is partly due to their highly specific targeting of antigens as well as their high efficacy and fewer side effects. Vaccines and effective antibody therapeutics will play an integral role in keeping the on-going COVID-19 pandemic and emerging variants…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
HIV patients are more likely to die from COVID-19 infection – News-Medical.Net
Article feature image
Study confirms rare blood clotting risk linked to ChAdOx1-S vaccine – benefits still outweigh risks – News-Medical.Net